GST, CYP and PON1 polymorphisms in farmers attributing ill health to organophosphate-containing sheep dip

Biomarkers

Volumn 12, Issue 2, 2007, Pages 188-202

  Povey, A C ^a   Jury, F ^a   Dippnall, W M ^a   Smith, A E ^a   Thomson, S ^a   Mackness, B ^b   Mackness, M ^b   Durrington, P ^b   Cherry, N M ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c Department of Public Health Sciences ^*  (Canada)

Author keywords

CYP; GST; Organophosphates; Paraoxonase; PON1; Sheep dip

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CYTOCHROME P450; CYTOCHROME P450 2D6; DIMPYLATE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M2; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; GLUTATHIONE TRANSFERASE T2; ORGANOPHOSPHATE INSECTICIDE; TRANSFERASE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT; ARYLDIALKYLPHOSPHATASE; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GSTP1 PROTEIN, HUMAN; INSECTICIDE; ORGANOPHOSPHATE;

ADULT; AGRICULTURAL WORKER; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; INTOXICATION; MALE; NULL ALLELE; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; POPULATION RESEARCH; RISK ASSESSMENT; SHEEP FARMING; WILD TYPE; AGRICULTURE; ANIMAL; GENETIC PREDISPOSITION; GENETICS; SHEEP;

CINCLIDAE; OVIS ARIES;

AGRICULTURE; ANIMALS; ARYLDIALKYLPHOSPHATASE; CYTOCHROME P-450 CYP2D6; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; INSECTICIDES; OCCUPATIONAL EXPOSURE; PHOSPHORIC ACID ESTERS; POLYMORPHISM, GENETIC; SHEEP, DOMESTIC;

EID: 34347219471     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500601043500     Document Type: Article

References (51)

1. Abel, EL, Bammler, TK and Eaton, DL (2004) Biotransformation of methyl parathion by glutathione S-transferases. Toxicological Sciences, 79, pp. 224-232.
2. Ali-Osman, F., Akande, O., Antoun, G., Mao, JX and Buolamwini, J. (1997) Molecular cloning, characterisation, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalyic activity of the encoded proteins. Journal of Biological Chemistry, 272, pp. 10004-10012.
3. Bradford, LD (2002) CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics, 3, pp. 229-243.
4. Cherry, N., Creed, F., Silman, A., Dunn, G., Baxter, D., Smedley, J., Taylor, S. and Macfarlane, GJ (2001) Health and exposures of United Kingdom Gulf War Veterans. Part I: The pattern and extent of ill health. Occupational and Environmental Medicine, 58, pp. 291-298.
5. Cherry, NM, Mackness, M., Durrington, P., Povey, AC, Dippnall, WM, Smith, AE and Mackness, B. (2002) Paraoxonase (PON1) polymorphisms in farmers attributing ill-health to sheep dip. Lancet, 359, pp. 763-764.
6. (1999) Department of Health
7. Costa, LG, Cole, TB, Jarvik, GP and Furlong, CE (2003) Functional genomic of the paraoxonase (PON1) polymorphisms: Effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annual Review of Medicine, 54, pp. 371-392.
8. Davies, HG, Richter, RJ, Keifer, M., Broomfield, CA, Sowalla, J. and Furlong, CE (1996) The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nature Genetics, 14, pp. 334-336.
9. Dillon, HH and Ho, MH (1987) Biological monitoring of exposure to organophosphorus pesticides. Biological Monitoring of Exposure to Chemicals. Organic Compounds, pp. 227-287. John Wiley & Sons, New York
10. Donn, R., Alourfi, Z., De Benedetti, F., Meazza, C., Zeggini, E., Lunt, M., Stevens, A., Shelley, E., Lamb, R., Ollier, WER, Thompson, W. and Ray, D. (2002) Mutation screening of the macrophage migration inhibitory factor gene: Positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. 46, pp. 2402-2409.
11. Eaton, DL (2000) Biotransformation enzyme polymorphism and pesticide susceptibility. Neurotoxicology, 21, pp. 101-112.
12. Fabrizi, L., Gemma, S., Testai, E. and Vittozzi, L. (1999) Identification of the cytochrome p450 isoenzymes involved in the metabolism of diazinon in the rat liver. Journal of Biochemical and Molecular Toxicology, 13, pp. 53-61.
13. Furlong, CE, Li, WF, Richter, RJ, Shih, DM, Lusis, AJ, Alleva, E. and Costa, LG (2000) Genetic and temporal determinants of pesticide sensitivity: Role of paraoxonase (PON1). Neurotoxicology, 21, pp. 91-100.
14. Garin, MC, James, RW, Dussoix, P., Blanche, M., Passa, P., Froguel, P. and Ruiz, J. (1997) Paraoxonase polymorphism Met-Leu 54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. Journal of Clinical Investigation, 99, pp. 62-66.
15. Helzlsouer, KJ, Selmin, O., Huang, HY, Strickland, PT, Hoffman, S., Alberg, AJ, Watson, M., Comstock, GW and Bell, D. (1998) Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. Journal of the National Cancer Institute, 90, pp. 512-518.
16. Hernandez, AF, Mackness, B., Rodrigo, L., Lopez, O., Pla, A., Gil, F., Durrington, PN, Pena, G., Perron, T., Serrano, JL and Mackness, MI (2003) Paraoxonase activity and genetic polymorphisms in greenhouse workers with long-term pesticide exposure. Human and Experimental Toxicology, 22, pp. 505-574.
17. Humbert, R., Adler, DA, Disteche, CM, Hassett, C., Omiecinski, CJ and Furlong, CE (1993) The molecular basis for the human serum paraoxonase activity polymorphism. Nature Genetics, 3, pp. 73-76.
18. Ingelman-Sundberg, M. (2005) Genetic polymorphisms of cytochrome p450 2D6 (CYP2D6): Clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics Journal, 5, pp. 6-13.
19. Jokanovic, M. (2001) Biotransformation of organophosphorus compounds. Toxicology, 166, pp. 139-160.
20. Kappers, WA, Edwards, RJ, Murray, S. and Boobis, AR (2001) Diazinon is activated by CYP2C19 in human liver. Toxicology and Applied Pharmacology, 177, pp. 68-76.
21. Kuehl, P., Zhang, J., Lin, Y., Lamba, J., Assem, M., Schuetz, J., Watkins, PB, Daly, A., Wrighton, SA, Hall, SD, Maurel, P., Relling, M., Brimer, C., Yasuda, K., Venkataramanan, R., Strom, S., Thummel, K., Boguski, MS and Schuetz, E. (2001) Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nature Genetics, 27, pp. 383-391.
22. La Du, BN, Billecke, S., Hsu, C., Haley, RW and Broomfield, CA (2001) Serum paraoxonase (PON1) isozymes: The quantitative analysis of isozymes effecting individual sensitivity to environmental chemicals. Drug Metabolism and Disposition, 29, pp. 566-569.
23. Lamba, JK, Lin, YS, Schuetz, EG and Thumme, KE (2002) Genetic contribution to variable human CYP3A-mediated metabolism. Advances in Drug Delivery Reviews, 54, pp. 1271-1290.
24. Lee, BW, London, L., Paulauskis, J., Myers, J. and Christiani, DC (2003) Association between human paraoxonase gene polymorphisms and chronic symptoms in pesticide-exposed workers. Journal of Occupational and Environmental Medicine, 45, pp. 118-122.
25. Lewis, SJ, Cherry, NM, McLNiven, R., Barber, PV and Povey, AC (2002) GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Letters, 180, pp. 165-171.
26. Li, W-F, Costa, LG, Richter, RJ, Hagen, T., Shih, DM, Tward, A., Lusis, AJ and Furlong, CE (2000) Catalytic efficiency determines the in vivo efficacy of PON1 for detoxifying organophosphorous compounds. Pharmacogenetics, 10, pp. 767-779.
27. Mackness, B., Durrington, PN and Mackness, MI (1998) Human serum paraoxonase. General Pharmacology, 31, pp. 329-336.
28. Mackness, B., Mackness, MI, Arrol, T., Turkie, W. and Durrington, PN (1998) Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modifications. FEBS Letters, 423, pp. 57-60.
29. Mackness, B., Durrington, P., Povey, AC, Thomson, S., Middleton, S., Dippnall, M., Mackness, M., Smith, AR and Cherry, NM (2003) Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep. Pharmacogenetics, 13, pp. 81-88.
30. May, DG, Porter, J., Wilkinson, GR and Branch, RA (1994) Frequency distribution of dapsone N-hydroxylase, a putative probe for p4503A4 activity in a white population. Clinical Pharmacology and Therapeutics, 55, pp. 492-500.
31. Menegon, A., Board, PG, Blackburn, AC, Mellick, GD and Couteur, DG Le (1998) Parkinson's disease, pesticides and glutathione transferase polymorphisms. Lancet, 352, pp. 1344-1346.
32. Mizutani, T. (2003) PM frequencies of major CYPs in Asians and Caucasians. Drug Metabolism Reviews, 35, pp. 99-106.
33. Motoyama, N. and Dauterman, WC (1980) Glutathione S-transferases: Their role in the metabolism of organophosphorous insecticides. Reviews in Biochemical Toxicology, 2, pp. 49-69.
34. Mutch, E., Blain, PG and Williams, FM (1999) The role of metabolism in determining susceptibility to parathion toxicity in man. Toxicology Letters, 107, pp. 177-187.
35. Povey, AC, Guppy, MJ, Hall, CN, Jackson, PE, Badawi, AF, Cooper, DP, O'Connor, PJ and Margison, GP (2001) Host determinants of DNA alkylation and DNA repair activity in human colorectal tissue: O 6-methylguanine levels are associated with GST-T1 genotype and O 6-alkylguanine-DNA alkyltransferase activity with CYP2D6 genotype. Mutation Research, 495, pp. 103-115.
36. Povey, AC, Mackness, MI, Durrington, PN, Dippnall, M., Smith, AE, Mackness, B. and Cherry, NM (2005) Paraoxonase polymorphisms and self-reported chronic ill-health in farmers dipping sheep. Occupational Medicine, 55, pp. 282-286.
37. Rebbeck, TR (1997) Molecular epidemiology of the human glutathione s-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiology Biomarkers Prevention, 6, pp. 733-743.
38. Rebbeck, TR, Jaffe, JM, Walker, AH, Wein, AJ and Malkowicz, SB (1998) Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. Journal of the National Cancer Institute, 90, pp. 1225-1229.
39. (1998) Organophosphate sheep dip: Clinical aspects of long term low-dose exposure. Royal College of Physicians of London and the Royal College of Psychiatrists, Royal College of Physicians of London and the Royal College of Psychiatrists, London
40. Sachse, C., Brockmoller, J., Bauer, S. and Roots, I. (1997) Cytochrome P450 2D6 variants in a Caucasian population: Allele frequencies and phenotypic consequences. American Journal of Human Genetics, 60, pp. 284-289.
41. Sams, C., Mason, HJ and Rawbone, R. (2000) Evidence for the activation of organophosphate pesticides by cytochromes p450 3A4 and 2D6 in human liver microsomes. Toxicology Letters, 116, pp. 217-221.
42. Sams, C., Cocker, J. and Lennard, MS (2004) Biotransformation of chlorpyrifos and diazinon by human liver microsomes and recombinant human cytochrome p450s (CYP). Xenobiotica, 34, pp. 861-873.
43. Sata, F., Sapone, A., Elizondo, G., Stocker, P., Miller, VP, Zheng, W., Raunio, H., Crespi, CL and Gonzalez, FJ (2000) CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: Evidence for an allelic variant with altered catalytic activity. Clinical Pharmacology and Therapeutics, 67, pp. 48-56.
44. Shih, DM, Xia, Y-R, Navab, M., Li, W-F, Hama, S., Castellani, LW, Furlong, CE, Costa, LG, Fogelman, AM and Lusis, AJ (1998) Mice lacking serum paroxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature, 394, pp. 284-287.
45. Smith, CAD, Gough, AC, Leigh, PN, Summers, BA, Harding, AE, Maranganore, DM, Sturman, SG, Schapira, AHV, Williams, AC, Spurr, NK and Wolf, CR (1992) Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet, 339, pp. 1375-1377.
46. Strange, RC, Spiteri, MA, Ramachandran, S. and Fryer, AA (2001) Glutathione-S-transferase family of enzymes. Mutation Research, 482, pp. 21-26.
47. Sultatos, LG (1992) Role of glutathione in the mammalian detoxication of organophosphorus insecticides. Organophosphates: Chemistry, fate and effects, pp. 155-168. Academic Press, San Diego
48. Thier, R., Pemble, SE, Kramer, H., Taylor, JB, Guengerich, FP and Ketterer, B. (1996) Human glutathione S-transferase T1-1 enhances mutagenicity of 1,2-dibromoethane, dibromomethane and 1,2,3,4-diepoxybutane in Salmonella typhimurium. Carcinogenesis, 17, pp. 163-166.
49. Westlind, A., Lofberg, L., Tindber, N., Andersson, TB and Ingelman-Sundberg, M. (1999) Interindividual differences in hepatic expression of CYP3A4: Relationship to genetic polymorphism in the 5'-upstream regulatory region. Biochemical and Biophysical Research Communications, 259, pp. 201-205.
50. Wolf, CR and Smith, G. (1999) Cytochrome P450 CYP2D6. IARC Scientific Publications, 148, pp. 209-229.
51. Zanger, UM, Raimundo, S. and Eichelbaum, M. (2004) Cytochrome p450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn-Schmiedeberg's Archives of Pharmacology, 369, pp. 23-37.